What Happens When Your Cataract Patient Also Has a Macular Disease?
Available from: 1/05/2025 ()
Where to publish: https://lms.optometry.org.au/course/view.php?id=874
Provider: Mivision
Activity Outline
Most Australians will undergo cataract surgery in their lifetime, and a significant number of these patients will also have ocular comorbidities such as macular disease and/or glaucoma. Historically, these patients would only be offered a monofocal intraocular lens (IOL) due to the risk of poor patient satisfaction resulting from reduced optical quality and dysphotopsia.
However, as lens technology has advanced, extended depth of focus (EDOF) IOLs are increasingly employed to minimise spectacle dependence following cataract surgery or refractive lens exchange. With improved contrast sensitivity and a reduced dysphotopsia side effect profile, it is possible that this generation of IOLs will become the standard of care in patients with ocular comorbidities, including macular disease.
Learning Objectives
- Be aware of key factors for consideration when selecting intraocular lenses for patients
- Understand how intraocular lenses work to enhance vision
- Realise the influence of macular pathology on lens surgery
- Be aware of how a macular pathology can influence IOL lens selection
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| What Happens When Your Cataract Patient Also Has a Macular Disease? |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |